Eddit

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(35 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
__NOTOC__
 
__NOTOC__
 
*'''[[Further reading]]'''
 
*'''[[Further reading]]'''
*[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper]
+
 
 +
 
 
*'''[[Unproven ideas]]'''
 
*'''[[Unproven ideas]]'''
 +
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
 
 
 
*'''[[Clinical guidelines and advice]]'''
 
*'''[[Clinical guidelines and advice]]'''
  
Zeile 11: Zeile 11:
  
 
*'''[[Respiration mgmt]]'''
 
*'''[[Respiration mgmt]]'''
{{tp|p=C7203031|t=ä. Clinical consensus recommendations regarding non-invasive respiratory support in  the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection? |pdf=|usr=}}
 
{{tp|p=C7144845|t=ä. Cuidado respiratorio en COVID-19 |pdf=|usr=}}
 
{{tp|p=32392023|t=2020. Sedation of Mechanically Ventilated COVID-19 Patients: Challenges and Special Considerations |pdf=|usr=}}
 
  
 
*'''[[Diagnosis (Laboratory)]]'''
 
*'''[[Diagnosis (Laboratory)]]'''
{{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
+
 
{{tp|p=C7169335|t=2020. Promising methods for detection of novel coronavirus SARS?CoV?2 |pdf=|usr=}}
+
{{tp|p=C7144506|t=2020. Technical guidance for laboratory testing of 2019-nCoV infection (Third Edition) |pdf=|usr=}}
+
{{tp|p=32382657|t=2020. Assay Techniques and Test Development for COVID-19 Diagnosis |pdf=|usr=}}
+
  
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
 
  
 
*'''[[Diagnosis (other modalities)]]'''
 
*'''[[Diagnosis (other modalities)]]'''
  
  
----
 
  
  
 
*'''[[Structure of covid19]]'''
 
*'''[[Structure of covid19]]'''
{{tp|p=32391184|t=2020. Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease |pdf=|usr=}}
 
  
  
 
*'''[[Target binding and uptake]]'''
 
*'''[[Target binding and uptake]]'''
 
 
*'''[[Cytopathic effects]]'''
 
*'''[[Cytopathic effects]]'''
 
*'''[[Secretion and shedding]]'''
 
*'''[[Secretion and shedding]]'''
Zeile 49: Zeile 38:
  
  
----
+
 
 
*'''[[Pathobiology]]'''
 
*'''[[Pathobiology]]'''
{{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}}
 
{{tp|p=32379077|t=2020. COVID-19: POSTMORTEM DIAGNOSTIC AND BIOSAFETY CONSIDERATIONS |pdf=|usr=}}
 
  
  
 
*'''[[Disease Models]]'''
 
*'''[[Disease Models]]'''
 
  
  
 
*'''[[Similar diseases and pathomechanisms]]'''
 
*'''[[Similar diseases and pathomechanisms]]'''
 +
  
  
Zeile 68: Zeile 55:
  
 
*'''[[Co-Infection]]'''
 
*'''[[Co-Infection]]'''
{{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
+
 
  
 
*'''[[Pulmonary embolism, coagulation]]'''
 
*'''[[Pulmonary embolism, coagulation]]'''
{{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}}
+
 
 +
 
  
  
Zeile 88: Zeile 76:
  
 
*'''[[Dermatology]]'''
 
*'''[[Dermatology]]'''
{{tp|p=32418860|t=ä. Lesiones cuteneas tipo perniosis durante la epidemia COVID-19 |pdf=|usr=}}
 
{{tp|p=32402775|t=ä. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19 |pdf=|usr=}}
 
  
  
  
 
*'''[[Gastroenterology, hepatology]]'''
 
*'''[[Gastroenterology, hepatology]]'''
{{tp|p=C7198139|t=2020. Suspected Acute Abdomen as an Extrapulmonary Manifestation of Covid-19 Infection? |pdf=|usr=}}
 
{{tp|p=C7180357|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? |pdf=|usr=}}
 
{{tp|p=C7172485|t=2020. SARS-CoV-2 Gastrointestinal Infection Causing Hemorrhagic Colitis: Implications for Detection and Transmission of COVID-19 Disease |pdf=|usr=}}
 
  
 
*'''[[Kidney, urology]]'''
 
*'''[[Kidney, urology]]'''
  
 
+
*'''[[The morbid survivor]]'''
  
 
*'''[[Risk and special populations]]'''
 
*'''[[Risk and special populations]]'''
  
 
 
*'''[[The morbid survivor]]'''
 
{{tp|p=C7192120|t=ä. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patients |pdf=|usr=}}
 
  
  
 
*'''[[Case reports]]'''
 
*'''[[Case reports]]'''
{{tp|p=C7148978|t=ä. A Cured COVID-19 case of 86-year-old with 13 chronic diseases: A Case Report |pdf=|usr=}}
 
{{tp|p=32381283|t=ä. Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease |pdf=|usr=}}
 
  
  
  
*'''[[Case series]]'''
 
{{tp|p=C7165248|t=2020. Auch Kinder können schwer an COVID-19 erkranken |pdf=|usr=}}
 
*'''[[Registries]]'''
 
----
 
  
  
*'''[[Trials]]'''
 
  
  
 +
*'''[[Case series]]'''
  
*'''[[Candidate Compounds Covid19]]'''
 
  
 +
*'''[[Registries]]'''
  
  
 +
*'''[[Trials]]'''
  
 +
*'''[[Candidate Compounds Covid19]]'''
  
  
 
*'''[[Other routes of infection]]'''
 
*'''[[Other routes of infection]]'''
{{tp|p=32376320|t=ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract |pdf=|usr=}}
 
  
  
 
*'''[[Biophysics of aerosols]]'''
 
*'''[[Biophysics of aerosols]]'''
  
*'''[[Passive protective equipment]]'''
 
{{tp|p=C7147274|t=ä. Prevention and Treatment of Skin Damage Caused by Personal Protective Equipment:  Experience of the First-Line Clinicians Treating 2019-nCoV Infection |pdf=|usr=}}
 
{{tp|p=C7148653|t=2020. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents |pdf=|usr=}}
 
{{tp|p=32389627|t=ä. Application of fluorescence method in the process of personal protective equipment removal |pdf=|usr=}}
 
  
 +
 +
 +
*'''[[Passive protective equipment]]'''
  
  
Zeile 151: Zeile 124:
  
 
*'''[[Mental aspects of health professionals]]'''
 
*'''[[Mental aspects of health professionals]]'''
 
  
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 +
 +
  
  
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 +
 +
  
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
Zeile 162: Zeile 138:
  
 
*'''[[Economic aspects of the status hygienicus]]'''
 
*'''[[Economic aspects of the status hygienicus]]'''
 +
  
 
*'''[[Educational aspects of the status hygienicus]]'''
 
*'''[[Educational aspects of the status hygienicus]]'''
Zeile 168: Zeile 145:
  
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
{{tp|p=C7149279|t=ä. Global implications of bio-aerosol in pandemic |pdf=|usr=}}
 
 
 
  
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
  
 
*'''[[Epidemiology]]'''
 
*'''[[Epidemiology]]'''
 +
 +
 +
 +
  
 
*'''[[Remission, recurrence and persistence]]'''
 
*'''[[Remission, recurrence and persistence]]'''
 +
 +
  
 
*'''[[Failure of executive measures]]'''
 
*'''[[Failure of executive measures]]'''
 
----
 
----
 
*'''[[Failure of politics and public health guidance]]'''
 
*'''[[Failure of politics and public health guidance]]'''
 
  
  
 
*'''[[Political abuse of Covid19]]'''
 
*'''[[Political abuse of Covid19]]'''
{{tp|p=C7166360|t=2015. Political Incentives to Suppress Negative Information: Evidence from Chinese Listed Firms |pdf=|usr=}}
+
 
  
  
Zeile 196: Zeile 175:
  
 
*'''[[History of covid19 exploration]]'''
 
*'''[[History of covid19 exploration]]'''
{{tp|p=C7147143|t=2020. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie |pdf=|usr=}}
+
*'''[[misc.]]'''
  
  
*'''[[misc.]]'''
+
*'''[[Research tools]]'''
  
  
  
*'''[[Research tools]]''
+
 
 +
{{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}}
 +
{{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}}
 +
 
  
 
*'''[[PrePrint scene]]'''
 
*'''[[PrePrint scene]]'''
 +
  
 
*'''[[from the ads]]'''
 
*'''[[from the ads]]'''
 +
 
*'''[[Current state of coviki.org]]'''
 
*'''[[Current state of coviki.org]]'''
 
*'''[[on-topic personal thoughts]]'''
 
*'''[[on-topic personal thoughts]]'''

Aktuelle Version vom 7. Juni 2020, 22:19 Uhr



















































27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system



Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis